<DOC>
	<DOCNO>NCT02651090</DOCNO>
	<brief_summary>Patients renal failure reason contraindication contrast enhance compute tomography ( CECT ) contrast enhance magnetic resonance imaging ( CEMRI ) suspect liver pathology evaluate Sonazoid enhance Ultrasound</brief_summary>
	<brief_title>Evaluation Suspected Liver Pathology Patients With Contraindications Contrast Enhanced CT and/or MRI</brief_title>
	<detailed_description>Patients diagnosis cancer high probability cancer ( primary ) contraindication contrast enhance Computed Tomography Magnetic Resonance Image ask participate study . Patients male female &gt; 18 year old . Contraindications computer tomography ( CT ) magnetic resonance imaging ( MRI ) would include , limited : 1 . Creatinine clearance &lt; 60 mg/dl 2 . Allergy iodinate contrast gadolinium base contrast agent 3 . History adverse event CT MRI contrast Up 100 patient enrol two year period . Statistical justification sample size Assuming non-enhanced CT detect characterize metastatic disease correctly 60 % time ( 2 ) Contrast enhance ultrasound ( CEUS ) detect characterize metastatic disease correctly 90 % time ( 3,4 ) , 100 % chance significant difference one-sided 0.05 significance level use Fisher Exact Test . CT MRI Patient receive non-contrast CT MRI would order routine state follow-up patient . At minimum 5mm contiguous axial slice obtain CT T1-weighted , T2-weighted , in-phase phase imaging perform MRI minimum slice thickness 5mm . Each lesion note within liver measure two dimension record . The lesion classify scale 1 - 5 regard probability benignity malignancy lesion . If diagnosis make diagnosis document The location lesion document Couinaud diagram . CEUSâ€”Contrast specific software optimize Sonazoid use vascular Kupffer phase imaging . The focus set lesion interest vascular phase image 4-8 cm leave lobe 8-10 cm right lobe Kupffer phase imaging . The lesion interest image 15 second injection 1 minute injection ( vascular phase image ) . No scan perform Kupffer phase imaging , begin 10 minute injection . The patient receive follow ultrasound imaging : 1 . Standard B-mode color-Doppler imaging . Elastography may add PI 's discretion . 2 . A 20g IV place antecubital vein 3 . Low MI scan use vascular phase . 4 . An intermediate MI scan use least 10 minute delay perform Kupffer scan 5 . If lesion identify Kupffer scan characterize without exam patient complete evaluation vascular phase second injection may use . Each lesion note within liver measure two dimension record . The lesion classify scale 1 - 5 regard probability benignity malignancy lesion . If diagnosis make diagnosis document . The location lesion document Couinaud Diagram . The gold standard either 1. characteristic enhancement pattern ( hemangioma , benign ) 2. lesion biopsy 3. growth lesion 6 month period time ( malignant ) Data Analysis For assessment characterization efficacy McNemar test use compare rate correct diagnosis lesion unenhanced ultrasound , CEUS unenhanced CT MRI . For assessment detection efficacy , Wilcoxon 's signed rank test use compare lesion detection rate obtain unenhanced ultrasound , CEUS , unenhanced CT MRI . For test , p &lt; 0.05 consider statistically significant difference .</detailed_description>
	<criteria>1 . Patients diagnosis cancer high probability cancer yet diagnose contraindication contrast CT MRI 2 . Age &gt; 18 year 3 . No know allergy Sonozoid 4 . Ability give inform consent 1 . No IV access 2 . Inability give inform consent 3 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>contraindication CECT</keyword>
	<keyword>contraindication CEMRI</keyword>
	<keyword>liver pathology</keyword>
	<keyword>renal failure</keyword>
	<keyword>contrast enhance ultrasound</keyword>
	<keyword>sonazoid</keyword>
</DOC>